| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,558 | 19,608 | 22,804 | 22,089 | | Cost of Revenue | 4,672 | 5,305 | 5,265 | 5,607 | | | Gross Profit | 11,886 | 14,303 | 17,539 | 16,482 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,522 | 7,805 | 7,503 | 5,665 | | Non Recurring | (9,103) | 23,036 |
-
|
-
| | Others | 2,454 | 14,131 | 4,915 | 6,014 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 15,013 | (30,669) | 5,121 | 4,803 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 15,013 | (30,669) | 5,121 | 4,803 | | Interest Expense | 1,771 | 1,771 | 1,760 | 1,943 | | Income Before Tax | 13,242 | (32,440) | 3,361 | 2,860 | | Income Tax Expense | 1,720 | (10,161) | 420 | 752 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,522 | (22,279) | 2,941 | 2,108 | | | Non-recurring Events | | Discontinued Operations | (9,617) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,905 | (22,279) | 2,941 | 2,108 | | Preferred Stock And Other Adjustments | (571) | (570) | (567) |
-
| | | Net Income Applicable To Common Shares | $1,334 | ($22,849) | $2,374 | $2,108 |
|
0.03% Nasdaq 0.00%
Income Statement
